Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Nawal Al Kaabi"'
Autor:
Rowan Abuyadek, Mira Mousa, Jumana AlAzazi, Ahmed Al Romaithi, Francis Selvaraj, Habiba Alsafar, Nawal Al Kaabi, Farida Al Hosani
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background In the pursuit of global health security, continuous monitoring of vaccine effectiveness across various viral strains emerges as a crucial imperative. The emergence of SARS-CoV-2 major variants of concern (VOCs), including Alpha,
Externí odkaz:
https://doaj.org/article/ec049990266549d0b33fa7a445684fca
Autor:
Jean Joury, Nawal Al Kaabi, Sara Al Dallal, Bassam Mahboub, Mostafa Zayed, Mohamed Abdelaziz, Jennifer Onwumeh-Okwundu, Mark A. Fletcher, Subramanyam Kumaresan, Badarinath C. Ramachandrachar, Mohamed Farghaly
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 11, Iss 2 (2024)
**Background:** Infections attributable to respiratory syncytial virus (RSV) are a major cause of hospitalization among young children worldwide. Despite substantial clinical and economic burden, real-world data associated with RSV infections in the
Externí odkaz:
https://doaj.org/article/84cafb89b1744634800aad5def791c1d
Autor:
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Ze Hua Lei, Hao Zhang, Shuai Shao, Zhao Ming Liu, Ning Liu, Xiang Zheng, Ji Guo Su, Sen Sen Yang, Xiangfeng Cong, Yao Tan, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Mengjie Yang, Islam Eltantawy, Peng Xiao, Fu Jie Shen, Jin Juan Wu, Zi Bo Han, Li Fang Du, Fang Tang, Shi Chen, Zhi Jing Ma, Fan Zheng, Ya Nan Hou, Xin Yu Li, Xin Li, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-11 (2023)
Abstract An ongoing randomized, double-blind, controlled phase 2 trial was conducted to evaluate the safety and immunogenicity of a mosaic-type recombinant vaccine candidate, named NVSI-06-09, as a booster dose in subjects aged 18 years and older fro
Externí odkaz:
https://doaj.org/article/4d623a0b2acb4327bb2ad5f697eb16f3
Autor:
Kuntal Das, Paramita Das, Raha Orfali, A. Ramya, Alex Joseph, Mohd. Imran, Syed Mohammed Basheeruddin Asdaq, Sultan Alshehri, Ali A. Rabaan, Mohammed Aljeldah, Bashayer M. AlShehail, Mohammed Alissa, Nawal Al Kaabi, Ameen S.S. Alwashmi, Mashael Alhajri, Mustafa A. Najim, Farhana Yasmin
Publikováno v:
Journal of King Saud University: Science, Vol 35, Iss 6, Pp 102737- (2023)
Background: Tuberculosis remains a ninth global health cause affecting millions of people. The susceptibility and resistance caused by first and second-line drugs have not changed for decades. There is a need to develop novel drugs with better pharma
Externí odkaz:
https://doaj.org/article/93f0919abb6e440f844198173d9ad8e6
Autor:
Nawal Al Kaabi, Yun Kai Yang, Li Fang Du, Ke Xu, Shuai Shao, Yu Liang, Yun Kang, Ji Guo Su, Jing Zhang, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Sen Sen Yang, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Xiangfeng Cong, Yao Tan, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Mengjie Yang, Islam Eltantawy, Jun Wei Hou, Ze Hua Lei, Peng Xiao, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
SARS-CoV-2 variants with immune escape capability highlight the need for the development of cross-neutralising vaccines and regimens. Here, the authors assess the immunogenicity and safety of NVSI-06-08, that integrates antigens from multiple SARS-Co
Externí odkaz:
https://doaj.org/article/f2cc9bdd0cd344e49d5f119c751716d3
Autor:
Nawal Al Kaabi, Yun Kai Yang, Jing Zhang, Ke Xu, Yu Liang, Yun Kang, Ji Guo Su, Tian Yang, Salah Hussein, Mohamed Saif ElDein, Shuai Shao, Sen Sen Yang, Wenwen Lei, Xue Jun Gao, Zhiwei Jiang, Hui Wang, Meng Li, Hanadi Mekki Mekki, Walid Zaher, Sally Mahmoud, Xue Zhang, Chang Qu, Dan Ying Liu, Mengjie Yang, Islam Eltantawy, Peng Xiao, Zhao Nian Wang, Jin Liang Yin, Xiao Yan Mao, Jin Zhang, Ning Liu, Fu Jie Shen, Liang Qu, Yun Tao Zhang, Xiao Ming Yang, Guizhen Wu, Qi Ming Li
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-11 (2022)
Abstract The increased coronavirus disease 2019 (COVID-19) breakthrough cases pose the need of booster vaccination. We conducted a randomised, double-blinded, controlled, phase 2 trial to assess the immunogenicity and safety of the heterologous prime
Externí odkaz:
https://doaj.org/article/c1df52b85da34e63b5c7dfaf04c077f6
Autor:
Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan, Farida Ismail Al Hosani, Omer Najim, Halah Ibrahim, Juan Acuna, Ahmed R. Alsuwaidi, Ashraf M. Kamour, Ashraf Alzaabi, Badreyya Ahmed Al Shehhi, Habiba Al Safar, Salah Eldin Hussein, Jehad Saleh Abdalla, Dalal Saeed Naser Al Mansoori, Ahmed Abdul Kareem Al Hammadi, Mohammed A. Amari, Ahmed Khamis Al Romaithi, Stefan Weber, Santosh Elavalli, Islam Eltantawy, Noura Khamis Alghaithi, Jumana Nafiz Al Azazi, Stephen Geoffrey Holt, Mohamed Mostafa, Rabih Halwani, Hanif Khalak, Wael Elamin, Rami Beiram, Walid Zaher
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
There is limited real-world evidence for the effectiveness of the BBIBP-CorV (Sinopharm) vaccine against severe COVID-19 disease. Here, the authors use data from Abu Dhabi and estimate effectiveness at 80% against hospitalization; 86% against critica
Externí odkaz:
https://doaj.org/article/19a1460856ae47bebeec36e571ab9520
Autor:
Mariam Al Harbi, Nawal Al Kaabi, Asma Al Nuaimi, Jehad Abdalla, Tehmina Khan, Huda Gasmelseed, Asad Khan, Osama Hamdoun, Stefan Weber
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was first reported in December 2019. The severity of coronavirus disease 2019 (COVID-19) ranges from asymptomatic to severe and potentially fatal. We aimed to descri
Externí odkaz:
https://doaj.org/article/4eac167bd46049bc99c8f5fe115638ad
Autor:
Nawal Al Kaabi, Abderrahim Oulhaj, Farida Ismail Al Hosani, Shamma Al Mazrouei, Omer Najim, Salah Eldin Hussein, Jehad Saleh Abdalla, Mohammed Saifuddin Fasihuddin, Afnan Abdellatif Hassan, Gehad Elghazali, Ahmed Al Rumaithi, Jumana Al Azazi, Stefan Weber, Rami Beiram, Khatija A. Parekh, Mohamud Sheek-Hussein, Yunkai Yang, Yang Xiaoming, Jenny Quliang, Islam Eltantawy, Sally Mahmoud, Ashish Koshy, Peng Xiao, Subhashini Ganesan, Wael Elamin, Walid Zaher
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Based on the findings from the Phase III clinical trials of inactivated SARS COV-2 Vaccine, (BBIBP-CORV) emergency use authorization (EUA) was granted for the vaccine to frontline workers in the UAE. A prospective cohort study was conducted
Externí odkaz:
https://doaj.org/article/62bfffa7b3d74e8abe3960160fdeb2d3
Autor:
Khalid Hajissa, Hammed-Akanmu Mutiat, Nawal Al Kaabi, Mohammed Alissa, Mohammed Garout, Anood A. Alenezy, Rana H. Almaghrabi, Hayam A. Alrasheed, Maha F. Al-Subaie, Hatem M. Alhani, Ahmad A. Alshehri, Ibrahim Abdullah Almazni, Ali S. Alqahtani, Fayez Saeed Bahwerth, Nourah Hashem Alqethami, Amal A. Alzayer, Ali A. Rabaan
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1070 (2023)
Despite the effectiveness of current vaccines in reducing the spread and severity of SARS-CoV-2 infections, many people, including migrants, refugees, and foreign workers, are hesitant to be vaccinated. This systematic review and meta-analysis (SRMA)
Externí odkaz:
https://doaj.org/article/740b915b24794dc58d51adc915456f96